Skip to main content
. 2011 Mar;71(3):429–436. doi: 10.1111/j.1365-2125.2010.03852.x

Figure 3.

Figure 3

Mean levels of DPP-4 inhibition in the plasma of young, healthy, fasted, male Japanese subjects (except as noted) given single oral doses of sitagliptin. The values in (A) were not corrected for dilution of plasma samples during the assay procedure. The values in (B) were corrected for this artifact following a previously described statistical procedure [14]. Japanese subjects received either placebo (Inline graphic and Inline graphic in panels A and B) or doses of 5 (Inline graphic), 12.5 (Inline graphic), 25 (Inline graphic), 50 (Inline graphic), 100 (Inline graphic), 200 (Inline graphic) and 400 (Inline graphic) mg sitagliptin. Historical data are included from young, healthy, fasted, non-Japanese male subjects given single oral doses of 50 (Inline graphic) and 100 (Inline graphic) mg sitagliptin